Tofacitinib is a janus kinase (JAK) inhibitor and disease modifying anti-rheumatic drug (DMARD). It works by suppressing the immune system and is used to treat certain inflammatory conditions.

Tofacitinib citrate is the first oral JAK inhibitor approved for use in chronic ulcerative colitis. Tofacitinib was initially not approved by European regulatory agencies because of concerns over efficacy and …

XELJANZ (tofacitinib) was the first FDA-approved pill of its kind (JAK inhibitor) that treats adults with moderate to severe rheumatoid arthritis, active psoriatic arthritis, active ankylosing spondylitis, and …

Jan 1, 2026 · Tofacitinib is a Janus kinase (JAK) inhibitor that works on the immune system. This medicine is available only with your doctor's prescription.

Tofacitinib is used to treat ulcerative colitis (a condition which causes swelling and sores in the lining of the colon [large intestine] and rectum) in adults who are unable to take or who did not respond to one …

Tofacitinib Citrate (Xeljanz) is an oral drug used to treat adults with moderately-severely active rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis, moderate to severe ulcerative …

What is this medication? TOFACITINIB (TOE fa SYE it nib) treats autoimmune conditions, such as arthritis and ulcerative colitis. It is prescribed when other medications have not worked or cannot be …

Dec 12, 2022 · Tofacitinib Adult Medication This information from Lexicomp ® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to …

Tofacitinib is a partial and reversible janus kinase (JAK) inihibitor that will prevent the body from responding to cytokine signals. By inhibiting JAKs, tofacitinib prevents the phosphorylation and …

Each 1 mL contains 1 mg of tofacitinib (equivalent to 1.62 mg of tofacitinib citrate) and the following inactive ingredients: grape flavor (natural), hydrochloric acid, lactic acid, purified water, sodium …